Marketing authorisation applications submitted to the European Medicines Agency by small and medium-sized enterprises: an analysis of major objections and their impact on outcomes
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference17 articles.
1. Regulatory watch: where do new medicines originate from in the EU?;Lincker;Nat. Rev. Drug Discov.,2014
2. The review of drug applications submitted to the European Medicines Evaluation Agency: frequently raised objections, and outcome;Pignatti;Eur. J. Clin. Pharmacol.,2002
3. Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products;Borg;J. Pharm. Pharm. Sci.,2009
4. Factors influencing non-approval of new drugs in Europe;Putzeist;Nat. Rev. Drug Discov.,2012
5. Typical pitfalls in applications for marketing authorization of biotechnological products in Europe;Schneider;Nat. Rev. Drug Discov.,2008
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Oncology Products in the European Union: An Analysis of Regulatory Approvals with a CHMP Oral Explanation;Therapeutic Innovation & Regulatory Science;2021-05-26
2. A Decade of Marketing Authorization Applications of Anticancer Drugs in the European Union: An Analysis of Procedural Timelines;Therapeutic Innovation & Regulatory Science;2021-02-04
3. Towards a better use of scientific advice for developers of advanced therapies;British Journal of Clinical Pharmacology;2020-12-11
4. Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals;Molecular Therapy - Methods & Clinical Development;2020-09
5. From Laboratory to Patient: The Evolving Path to Become a Medicine;Molecular Frontiers Journal;2019-11-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3